QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2023     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文 BMC CANCER, 2023, 卷号: 23 作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping 收藏  |  浏览/下载：4/0  |  提交时间：2023/11/10 Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival   Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文 BLOOD ADVANCES, 2023, 卷号: 7 作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe 收藏  |  浏览/下载：15/0  |  提交时间：2023/11/10 Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis 期刊论文 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 卷号: 15 作者:  Wang, Jingwen;  Zhang, Lijie;  Wang, Minghe;  Zhang, Jing;  Wang, Yaqi 收藏  |  浏览/下载：9/0  |  提交时间：2023/11/10 locally advanced rectal cancer  neoadjuvant chemoradiotherapy  organ preservation  total neoadjuvant therapy  watch-and-wait